Friday, 3 July 2020

Moderna became the first company to begin clinical trials on a vaccine

Interim phase 1 data showed that participants developed at least as many binding and neutralizing antibodies as recovered COVID-19 patients. Binding antibodies signal the presence of a pathogen, while neutralizing antibodies actually block infection.

https://slides.com/freevbucksgenerator
https://slides.com/freetiktokfanslikes

No comments:

Post a Comment